$74.59
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. The company is headquartered in Boston, Massachusetts and currently employs 3,023 full-time employees. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). The company also offers solutions for structural heart and endovascular procedures.
Country

US

CEO

Mr. Christopher Simon

IPO date

1979

Employees

3,023

ISIN

US4050241003

Key stats

Open

$75.00

Volume

424.01K

Market cap

$3.41B

Prev. close

$75.00

Impl / hst vl

-

Open interest

$0.00

$74.00

Day’s Range

$75.00

$51.00

52W Range

$86.11

Valuation

38
Valuation score
Overvalued
P/E
34.85
P/S
2.54
P/B
4.26
Current ratio
2.95
Debt / Equity
1.23
ROE
11.32%
Gross margin
57.25%
Income growth
-145.03%
FCF growth
-40.38

Analysts estimates

Consensus rating
Buy

The average rating from top 6 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$89.53
The top 11 analysts forecasts that 12-month price may increase by 20.03%, with a low of $70.70 and a high of $109.20
$70.70
Low
$89.53
Avg
$109.20
High
Current price

Earnings

Q1 ‘26 revenue
$346.35M
Q1 ‘26 net income
-$20.15M
Revenue
Net income
Previous EPS
$1.27
Estimate EPS
$1.26
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply